Roquefort Therapeutics plc (LON:ROQ)
London
· Delayed Price · Currency is GBP · Price in GBX 2.300
0.00 (0.00%)
Feb 21, 2025, 3:46 PM BST
Roquefort Therapeutics Market Cap
Roquefort Therapeutics has a market cap or net worth of 3.12 million as of February 21, 2025. Its market cap has decreased by -65.47% in one year.
Market Cap
3.12M
Enterprise Value
3.14M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.30
Market Cap Chart
Since March 22, 2021, Roquefort Therapeutics's market cap has increased from 2.19M to 3.12M, an increase of 42.75%. That is a compound annual growth rate of 9.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 3.12M | -43.21% |
| Dec 31, 2024 | 5.50M | -41.29% |
| Dec 29, 2023 | 9.36M | 9.43% |
| Dec 30, 2022 | 8.56M | 13.33% |
| Dec 31, 2021 | 7.55M | 245.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 181.54B |
| GSK plc | 58.32B |
| Haleon | 35.36B |
| Smith & Nephew | 9.01B |
| Hikma Pharmaceuticals | 5.12B |
| ConvaTec Group | 5.06B |
| HUTCHMED (China) | 2.19B |
| Genus | 1.17B |